switching from ozempic to semaglutide Mounjaro Switching between weight-loss medications -

Furthermore, no serious health risks have been associated with taking this medication long-term, and most people tend to tolerate the drug very well

Research shows that 80% of responsive obese PCOS patients experienced menstrual cycle normalization with semaglutide treatment, while achieving average weight loss of 11.5 kg over six months nearly three times the results seen with metformin alone

dose adjustments of these medications may be necessary [1] [3] Acute pancreatitis rare but serious

PMC12151102

This may include diagnostic tests, imaging results, and physician notes

However, semaglutide has cardiovascular outcome data (the SELECT trial) that tirzepatide does not yet have from a completed dedicated outcomes trial